BCG-mediated bladder cancer immunotherapy: identifying determinants of treatment response using a calibrated mathematical model.

BCG-mediated bladder cancer immunotherapy: identifying determinants of treatment response using a calibrated mathematical model.

Intravesical Bacillus Calmette Guérin (BCG) immunotherapy is considered the standard of care for treatment of non-muscle invasive bladder cancer; however the treatment parameters were established empirically. In order to evaluate potential optimization of clinical parameters of BCG induction therapy...

Full description

Bibliographic Details
Main Authors: Cyrill A Rentsch, Claire Biot, Joël R Gsponer, Alexander Bachmann, Matthew L Albert, Romulus Breban
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3581521?pdf=render

Internet

http://europepmc.org/articles/PMC3581521?pdf=render

Similar Items